Skip to main content
  • Sharing our positive Phase 3 results evaluating MaaT013 in treating acute Graft-versus-Host Disease with gastrointestinal involvement

For more information, visit: https://microbiome-europe.com/ 

MaaT Pharma dans les médias MaaT Pharma in the News Devenez membre du club Become a member of the club